Pain Detection and Interception in Neonates
Not Applicable
- Conditions
- Pain DetectionPain Intervention
- Registration Number
- NCT00447824
- Lead Sponsor
- Sorlandet Hospital HF
- Brief Summary
Hypothesis:
1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample
2. Compare the effect of venous and capillary blood sample method
- Detailed Description
introducing the: Newborn Individualized Developmental Care and Assessment Program
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
- Born gestation age 31-36
Exclusion Criteria
- Infection, respiratory distress
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method value of Premature Infant Pain Profile Heart rate Saturation Skin conductance changes
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pain perception in neonates during invasive procedures like blood sampling?
How does the NIDCAP intervention compare to standard-of-care pain management in neonatal intensive care units?
Are there specific biomarkers that correlate with neonatal pain response during venous versus capillary blood sampling?
What are the potential adverse events associated with NIDCAP implementation in neonatal pain management?
What combination therapies or alternative interventions have been explored for neonatal pain interception alongside NIDCAP?
Trial Locations
- Locations (1)
Sorlandet Hospital SSHF
🇳🇴Kristiansand, Vest Agder, Norway
Sorlandet Hospital SSHF🇳🇴Kristiansand, Vest Agder, NorwayLiv NormannSub InvestigatorRandi S DahlSub Investigator